Linzagolix
Back to searchMolecule Structure
Scientific Name
Linzagolix
Description of the Drug
Linzagolix is a selective gonadotropin-releasing hormone (GnRH) receptor antagonist used for the symptomatic treatment of uterine fibroids.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB17083
http://www.drugbank.ca/drugs/DB17083
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Gonadotropin-releasing hormone receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL1855 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2333748 |
| DrugBank | DB17083 |
| PubChem: Thomson Pharma | 26516783 |
| PubChem | 16656889 |
| Nikkaji | J3.064.334H |
| BindingDB | 160329 |
| ChemicalBook | CB54844986 |
| ZINC | ZINC000043152963 |
